Detection of the tripeptide Tyr-Gly-Gly, a putative enkephalin metabolite in brain, using a sensitive radioimmunoassay  by Llorens-Cortes, Catherine et al.
Volume 189, number 2 FEBS 2933 September 1985 
Detection of the tripeptide Tyr-Gly-Gly, a putative 
enkephalin metabolite in brain, using a sensitive 
radioimmunoassay 
Catherine Llorens-Cortes, Jean-Charles Schwartz and Claude Gros 
Unit6 de Neurobiologie, Centre Paul Broca de I’INSERM, 2 ter rue d’Al&ia, 75014 Paris, France 
Received 30 July 1985 
A sensitive and specific radioimmunoassay has been developed for YGG. The tripeptide was previously de- 
rivatised with p-benzoquinone to prepare the immunogen and the lzsI tracer as well as in samples submitted 
to the RIA. The sensitivity isabout 1 nM as compared with 8000 nM for underivatised YGG. Measurable 
amounts of endogenous YGG immunoreactivity, co-eluting in HPLC with authentic YGG, were detected 
in mouse striatal extracts. 
Enkephalin metabolism Tyr-Gly-Gly Radioimmunoassay 
1. INTRODUCTION 
The enkephalins (YGGFM or YGGFL) are 
substrates for a variety of peptidases but only two 
enzyme activities appear to be involved in their 
physiological inactivation [l] : an aminopeptidase 
activity, sensitive to bestatin [2], responsible for 
the cleavage of the YG bond and ‘enkephalinase’ 
(EC 3.4.24.11) [3], inhibited by Thiorphan [4] and 
responsible for the cleavage of the GF bond. 
Hence the YGG fragment constitutes one of the 
characteristic reaction products of enkephalinase 
and its tissue level might potentially constitute an 
index of opioid peptide release. We have developed 
a RIA for this tripeptide to explore this possibility. 
2. MATERIALS AND METHODS 
Chemicals were from the following sources: syn- 
thetic peptides from Bachem, Bubendorf, 
Switzerland; 1 ,Cbenzoquinone, puriss. grade, 
from Fluka AG, Switzerland; polyethylene glycol 
6000 from Touzart et Matignon, Paris; organic 
solvents, analytical grade, from Merck, Darmstadt 
and other chemicals from Sigma, USA. [3H]Tyr- 
Gly-Gly was prepared by hydrolysis of 
[3H](Met’)enkephalin (Amersham, England) using 
a highly purified preparation of kidney 
enkephalinase [5] and isolated by polystyrene bead 
column chromatography [6]. Its radioactive purity 
was checked by HPLC [5]. 
2.1. Immunogen preparation 
The tripeptide YGG was cross-linked to bovine 
serum albumin (BSA) using 1 ,Cbenzoquinone 
(Bzq) in two steps [7]: 8 mg BSA dissolved in 2 ml 
of 0.1 M phosphate buffer, pH 6, containing 
0.15 M NaCl, were treated with 15 mg Bzq dis- 
solved in 0.5 ml EtOH. The solution was kept for 
1 h at room temperature, then filtered through a 
Sephadex G-25 column (1.5 x 5 cm) equilibrated 
in 0.15 M NaCl with which elution was thereafter 
performed. The first coloured peak (3.5 ml) cor- 
responding to Bzq-BSA was mixed with 12 mg 
YGG dissolved in 0.5 ml of 0.5 M carbonate buf- 
fer, pH 9. After 24 h at room temperature, the 
reaction was stopped by addition of 0.5 ml of 1 M 
lysine, pH 7.5, and the mixture was dialysed 
against 0.15 M NaCl. Using [‘H]YGG as tracer, it 
was estimated that approx. 30 molecules of YGG 
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were conjugated to each BSA molecule, i.e. 
150 pg/mg BSA. 
2.2. Antiserum production 
The YGG-Bzq-BSA conjugate (4 mg/animal) 
was emulsified in complete Freund’s adjuvant and 
injected intradermally at multiple sites along the 
back of 3 rabbits. Booster immunisations (2 then 
1 mg) with incomplete Freund’s adjuvant were ad- 
ministered at approximately two weekly intervals, 
until antibodies of sufficient titre and affinity were 
generated. 
2.3. Preparation of tissue extracts 
Mouse striata were homogenised in 30 vols of 
0.4 N HC104. After centrifugation (15000 x 
g - min), clear supernatants were adjusted to pH 6 
and stored at - 20°C until used. After thawing and 
centrifugation (15 000 x g - min), 1 ml of the clear 
extract was chromatographed on a column of 
bonded SiOz (Sep-Pak Cis, Waters). The column 
was washed with 0.5 ml Hz0 and YGG eluted with 
1.5 ml MeOH, the recovery being of 80%, as 
determined using [3H]YGG. The eluates were dried 
under reduced pressure, redissolved in 0.2 ml Hz0 
and submitted to HPLC on a Cl8 PBondapak col- 
umn. Elution was performed with Hz0 at a rate of 
1.5 ml/min and 1.5 ml fractions, collected during 
20 min, were lyophilised. Residues were redis- 
solved in 0.1 ml H20. 
2.4. Derivatisation of samples with 
p-benzoquinone 
To 0.1 ml samples of tissue extracts or solutions 
of peptide standards were added 75 pg Bzq dis- 
solved in 0.1 ml EtOH and 0.05 ml of 0.08 M 
phosphate buffer, pH 6. After 18 h at 2O”C, the 
excess of Bzq was removed by extraction into 
0.7 ml CHCl3, and aliquots of the aqueous phase 
used for the RIA. 
2.5. Preparation of the tracer 
To 1 mg (3.4,umol) of YGG and lo5 dpm of 
[3H]YGG dissolved in 0.4 ml of 0.1 M phosphate 
buffer, pH 6, were added 6 mg (56pmol) of Bzq, 
dissolved in 0.1 ml EtOH and the mixture left at 
room temperature for 1 h. The excess of Bzq was 
removed by extraction into CHCl3 and the aqueous 
phase spotted onto a silica gel plate and submitted 
to TLC, using nBuOH/AcOH/HzO (4 : 1: 1) as sol- 
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vent. Bzq-YGG (RF = 0.58), clearly separated 
from YGG (RF = 0.28), and representing about 
50% of the total (evaluated as described in legend 
of fig.1) was extracted from the plate. To 385 pg 
(1 pmol) of Bzq-YGG dissolved in 0.1 M car- 
bonate buffer, pH 9, were added 885 pg (3 pmol) 
of YGG in a final volume of 0.5 ml; the solution 
was left at room temperature for 18 h and, then 
submitted to TLC as above. The new spot (RF = 
O.lO), presumably corresponding to YGG-Bzq- 
YGG, was extracted into 0.05 M phosphate buf- 
fer, pH 7.4, to obtain a 0.5 mg/ml solution. 20~1 
of this solution were treated with 1 mCi of Na1251 
(spec. act. 2000 Ci/mmol, Amersham, England) 
dissolved in 10 pl in a tube coated with iodogen [8]. 
After a 20 min reaction time, the formed “‘I- 
YGG-Bzq-YGG was isolated by TLC in the system 
described above (RF = 0.19). 
2.6. Radioimmunoassay procedure 
The diluent for reagents was 0.1% BSA made up 
in 50 mM phosphate buffer, pH 7.4. Standard and 
sample curves were run in triplicate. 
Derivatised materials (0.1 ml), i.e. tissue ex- 
tracts of pure peptides, were mixed with the 1251 
tracer and diluted antiserum in a final volume of 
0.3 ml. The mixture was incubated either for 2 h at 
37°C or for 15-18 h at 4”C, then kept in an ice- 
bath for 30 min. After addition of 0.1 ml of 0.5% 
bovine y-globulin solution and 0.5 ml of 17% 
polyethylene glycol solution, the tubes were 
vortexed and centrifuged at 3000 x g for 20 min. 
The supernatants were discarded and pellets 
counted in a y counter. 
Results were expressed as percent of displace- 
ment of bound “‘1 tracer as a function of displacer 
concentration and I& values determined. 
3. RESULTS AND DISCUSSION 
A sensitive RIA for such a short peptide as YGG 
could be developed owing to its derivatisation with 
Bzq, according to a procedure previously used to 
attach covalently antibodies to enzymes [7]. This 
method was presently applied to raise antibodies 
against YGG in rabbits, to obtain a suitable 1251 
tracer and to pretreat issue samples to increase the 
assay sensitivity. 
Thus, whereas the alternative tracer ‘251-YGG 
shows no significant binding to antisera, the tracer 
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1251-YGG-Bzq-YGG allowed the selection of an 
antiserum giving a B,, value of 25% at a dilution of 
1/18ooo. 
In addition, derivatisation of YGG by Bzq 
decreased its I& value from 8000 to 1 nM (fig.2), 
allowing the detection of about 10 pg of YGG per 
assay. However, a reliable RIA requires that 
derivatisation should be performed in a quan- 
titative and reproducible manner. To meet this re- 
quirement, the experimental conditions for Bzq 
coupling to YGG (time, pH, reagent concentra- 
tions) were studied, taking into account the in- 
terference of endogenous reacting compounds in 
tissue samples. Under the selected conditions, the 
reaction was complete after 18 h (fig.1) and a 
tracer amount of [3H]YGG, added to a tissue ex- 
tract, coupled to the extent of 92 f 10% (mean f 
SE of 5 experiments). 
In spite of the small size of YGG, limited cross- 
reactivities with parent peptides like YG, YG-NH2, 
FGG, MGG or the enkephalins, were found 
(fig.2). The very low cross-reaction of Y (~0.01%) 
is of particular interest in view of the relatively 
high tissue level of this amino acid. 
TIME (ham) 
Fig. 1. Derivatisation of Tyr-Gly-Gly with p- 
benzoquinone. To YGG (10 ng) and [3H]YGG (lo5 dpm 
i.e. 300 pg) dissolved in 0.1 ml H20, were added 75 ,ug 
Bzq dissolved in 0.1 ml EtOH and 0.05 ml phosphate 
buffer (0.08 M, pH 6) and the reaction developed at 
20°C for the indicated uration. After removal of the 
excess of Bzq by CHCls extraction, aliquots were 
submitted to silica gel TLC using nBuOH/AcOH/HzO 
(4 : 1: 1). Radioactivity of the spots was evaluated with a 
scanner (Berthold, FRG). RF values: 0.28 (YGG) and 
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Fig.3. HPLC elution pattern of a Tyr-Gly-Gly standard 
and Tyr-Gly-Gly immunoreactivity from an extract of 
mouse striatum. Samples (0.2 ml) were injected into a 
Cl8 ,uBondapak column, elution performed with pure 
water at a rate of 1.5 ml/min and fractions 
radioimmunoassayed. Retention times were 5 min (Y), 
7 min (YG), 8 min (YGG), >20 min (enkephalins). The 
recovery of YGG-immunoreactivity in tubes 6-8 was 
0.58 (Bzq-YGG). about 95% of the injected material. 
lot 
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Fig.2. Cross-reactions of antibodies raised against Tyr- 
Gly-Gly with various compounds. Tyr and all peptides 
were prederivatised with Bzq as described in section 2 
and incubated in the presence of 10 pM lz51 tracer and 
the antiserum (l/18000). The I& value of non- 
derivatised YGG was 8000 nM (not shown). 
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When the RIA was applied to a mouse striatal 
extract, displacement of the bound tracer, parallel- 
ing that of authentic YGG, was observed (not 
shown). Furthermore, the immunoreactivity co- 
eluted with authentic YGG on a HPLC column 
(fig.3). 
From this experiment a striatal level of YGG of 
4.3 pmol/mg protein could be calculated, 
representing about l/10 that of enkephalins [9]. A 
variety of other data support the,idea that YGG is 
in a dynamic state in brain and largely arises from 
endogenous enkephalin breakdown. For instance, 
the regional distribution of YGG parallels to a 
large extent that of fragments of the proenkephalin 
molecule; YGG recovery, mainly in soluble 
subcellular fractions, is consistent with its ex- 
traneuronal ocalisation; finally its level is rapidly 
and markedly altered by inhibition of peptidases 
known to be responsible for endogenous 
enkephalin metabolism ([lo]; in preparation). 
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